PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


Growth in 3 years

Total Asset Growth
26.45%

Total Liabilities growth
9.50%

Reserves Change
-6.41%



Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth with a of %

Our Research Reports

Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.

View More

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

FnO

A snapshot on how the stock has performed in the derivatives segment on a real-time basis.

View More

MF Holdings

Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.

Scheme Name AUM (%) CMV ( in Cr.) Holding Date
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
View More

News

Stay tuned to the latest developments and happenings in the company.

Dr Lal Pathlabs allots 3,000 equity shares under ESOP

Dr Lal Pathlabs has allotted 3,000 equity shares under ESOP on 05 December 2024. Pursuant to the above allotment, the Paid-up Equity Share Capital of ....

05 Dec 2024 18:16

Dr. Lal PathLabs allots Equity shares

Dr. Lal PathLabs approved allotment of 5,000 Equity Shares under the ESOP 2010 Plan of the Company on 30th October 2024 through circular resolution.<p....

30 Oct 2024 11:47

Dr Lal Pathlabs consolidated net profit rises 18.21% in the September 2024 quarter

Net profit of Dr Lal Pathlabs rose 18.21% to Rs 129.20 crore in the quarter ended September 2024 as against Rs 109.30 crore during the previous quarte....

23 Oct 2024 17:47

Board of Dr. Lal PathLabs recommends Second Interim dividend

Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 23 October 2024, inter alia, have recommended the Second ....

23 Oct 2024 16:18

Dr Lal Pathlabs consolidated net profit rises 28.81% in the June 2024 quarter

Net profit of Dr Lal Pathlabs rose 28.81% to Rs 106.40 crore in the quarter ended June 2024 as against Rs 82.60 crore during the previous quarter ende....

07 Aug 2024 16:26

Dr Lal Pathlabs consolidated net profit rises 49.03% in the March 2024 quarter

Net profit of Dr Lal Pathlabs rose 49.03% to Rs 84.50 crore in the quarter ended March 2024 as against Rs 56.70 crore during the previous quarter ende....

10 May 2024 14:22

View More
Subscribe for our
newsletter
Open Account Now